U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07424183) titled 'T4/T3 Therapy in Hypothyroidism' on Feb. 06.
Brief Summary: This study will test whether 6 months of combination therapy with levothyroxine (LT4) plus liothyronine (LT3) is superior to LT4 plus placebo in participants with hypothyroidism who have residual symptoms of hypothyroidism with TSH levels within the reference range.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Hypothyroidism Primary
Intervention:
DRUG: Liothyronine (L-T3)
Participants will either take LT3 with an LT4 dose that is reduced from baseline or they will take liothyronine placebo with their baseline LT4 dose.
DRUG: Levothyroxine Sodi...